Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Proof of Concept Study of Pipamperone/Citalopram (PipCit) Versus Citalopram in the Treatment of Major Depressive Disorder (MDD)

NCT00672659 is registered in ClinicalTrials.gov with PharmaNeuroBoost N.V. as lead sponsor.

NCT NCT00672659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00672659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Proof of Concept Study of Pipamperone/Citalopram (PipCit) Versus Citalopram in the Treatment of Major Depressive Disorder (MDD)
Lead sponsor
PharmaNeuroBoost N.V.
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
January 31, 2009
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression